goodwill
发表于 2025-3-23 11:11:00
http://reply.papertrans.cn/71/7036/703527/703527_11.png
饥荒
发表于 2025-3-23 16:56:47
http://reply.papertrans.cn/71/7036/703527/703527_12.png
avulsion
发表于 2025-3-23 21:24:17
http://reply.papertrans.cn/71/7036/703527/703527_13.png
flimsy
发表于 2025-3-24 01:05:51
http://reply.papertrans.cn/71/7036/703527/703527_14.png
出没
发表于 2025-3-24 02:31:13
http://reply.papertrans.cn/71/7036/703527/703527_15.png
信徒
发表于 2025-3-24 08:30:11
Strategies to Overcome the Enzymatic Barrier,e regarded as one main reason for their poor bioavailability after peroral administration. Within the current chapter, strategies to overcome the so-called enzymatic barrier are described. Besides formulations that can protect the drug from enzymatic digestion via, e.g., drug encapsulation and chemi
出没
发表于 2025-3-24 10:50:33
http://reply.papertrans.cn/71/7036/703527/703527_17.png
可触知
发表于 2025-3-24 18:38:55
http://reply.papertrans.cn/71/7036/703527/703527_18.png
使人入神
发表于 2025-3-24 20:30:40
Strategies to Overcome Efflux Pumps,tics, antivirals, calcium channel blockers, immunosuppressive agents, peptide drugs and several other therapeutic compounds have been reported to be substrates of one or more transmembrane efflux transporters..Inhibition of these efflux pumps by various compounds can lead to enhanced absorption of s
Constitution
发表于 2025-3-24 23:34:32
http://reply.papertrans.cn/71/7036/703527/703527_20.png